comprehensive -WSS

comprehensive

author：knowledge 2025-09-27 09:57:40 - browse：44311

A hand in pink glove holds a blue rack that contains three tubes of blood samples — first opinion coverage from STAT — Joe Raedle/Getty Images

During my 25 years working in clinical trial operations, I’ve seen the biopharmaceutical world talk a big game about making the process easier for the sites running the trials and the patients participating in them. Everyone from trial sponsors to the Food and Drug Administration has been quick to promise simpler processes, less hassle, and better experiences for everyone involved.

But look closer, and you’ll see that these grand promises often fall apart when sponsors implement complicated plans for collecting blood, tissue and other biospecimens and impossible processes for managing those samples. Behind all the talk and regulatory guidance, there’s a reluctance to change how these essential elements of clinical trial execution are handled, putting the very ideals that sponsors are trying to uphold at risk.

The concept of site and patient centricity frequently gets reduced to addressing only superficial gestures, such as committing to promptly paying sites for their work or using tablets for conducting patient surveys. But the essence of centricity extends far beyond these surface-level measures. It lies in addressing the unseen and unmentioned complexities of clinical trials and providing real solutions that focus on truly prioritizing the needs of trial sites and participants.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Researchers test human milk's ability to repair gut microbiome

leisure time

WSS

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Biden administration opens offers in Medicare drug price negotiations

U.K. decision on ALS drug has neurologists, advocates up in arms

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Study: Black kids more likely to die after surgery than white kids

Trial using CRISPR to edit HIV out of cells disappoints

knowledge

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Pancreatic cancer is often deadly, but new discoveries are raising hope

Apple is now the first public company to be valued at $3 trillion

Apple Vision Pro: A first look at health apps on the new VR headset

Wildfire smoke exposes gaps in outdoor worker protections

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Sports medicine is finally prioritizing gender equality

Quicker fix for pulse oximeters urged during FDA public meeting

After affirmative action ruling, medical educators look to 'holistic review'

Drug companies' payments and gifts affect physicians' prescribing

hotspot

Time to name cancers by genetics, not organ of origin, expert says

Overprescribed: High cost isn't America's only drug problem

General Catalyst, Summa Health deal will turn on physician buy

Covid silver lining: Unprecedented look at human immune system

Study: Black kids more likely to die after surgery than white kids

Commercial surrogacy can be ethical, despite pope’s claims

entertainment

leisure time

explore

leisure time